Cyclerion Therapeutics, Inc.·4

Jun 18, 4:17 PM ET

Isacson Ole 4

4 · Cyclerion Therapeutics, Inc. · Filed Jun 18, 2020

Insider Transaction Report

Form 4
Period: 2020-06-16
Isacson Ole
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-06-16+10,00010,000 total
    Exercise: $4.46Exp: 2030-06-16Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION